Testing the Gravitostat in Humans: the Impact of a Weighted Vest in Patients Post Bariatric Surgery on Fat-free Mass Retention and Weight Loss

October 10, 2022 updated by: University College Dublin

The mechanisms regulating fat mass homeostasis are incompletely understood although recent animal and human trials would suggest that there is a leptin independent regulatory pathway which may play a role in weight control and maintenance. Although evidence would suggest that external loading in patients with obesity may promote body weight loss, this has not been explored in patients following bariatric surgery.

The aim of this study is to investigate the mechanisms regulating weight loss and the potential role of the 'gravitostat' in fat free mass retention in patients following bariatric surgery.

Study Overview

Status

Suspended

Conditions

Intervention / Treatment

Detailed Description

The aim of the study is to investigate the mechanisms that regulate weight loss, particularly following bariatric surgery. Previous animal studies have suggested that there is an underlying regulatory process controlled by 'the gravitostat' which is an evolutionary adaptation responsible for weight control and maintenance. Studies exploring this concept in rodent models have suggested that artificially increasing the animal's weight with the implantation of weighted capsules results in greater weight loss in mice with obesity but does not affect those of normal weight. We will use weighted vests in patients following surgery to replicate this increased mechanical loading to determine whether a similar process occurs in humans. This will improve our understanding of the underlying processes regulating weight in patients with obesity and following bariatric surgery.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dublin, Ireland, Dublin 4
        • University College Dublin Clinical Research Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Undergoing bariatric surgery- Roux en Y gastric bypass or sleeve gastrectomy
  • Age 18-60
  • BMI >30kg/m2
  • Reporting regular physical exercise (>3 days/week)
  • Willingness to comply with the study protocol

Exclusion Criteria:

  • Sedentary lifestyle
  • Chronic pain that is constant and impairs the quality of life such as severe back, hip or knee pain
  • Reduced mobility requiring the use of a mobility aid
  • Undergoing revisional surgery
  • Concerns from the investigator that the participant will be unable to fully comply with the study protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: External mechanical loading

Following bariatric surgery (RYGB or SG) patients will be asked to wear a weighted vest for a minimum of 8 hours daily and during physical exercise for three months postoperatively.

Weight will be incrementally added on a weekly basis to maintain the baseline weight as patients lose weight following surgery up to a maximum of 15%.

Patients will wear a weighted vest following bariatric surgery with weight increased incrementally to maintain baseline weight. This vest will be worn for a minimum of 8 hours a day for three months postoperatively.
NO_INTERVENTION: Standard postoperative care
Patients following bariatric surgery (RYGB or SG) will receive standard postoperative care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fat free mass retention
Time Frame: 1 year
Fat free mass retention as measured using DEXA scan
1 year
Weight loss
Time Frame: 1 year
Weight loss (kg)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in protein and inflammatory marker levels myostatin
Time Frame: 1 year
Change in myostatin
1 year
Changes in protein and inflammatory markers lipocalin-2
Time Frame: 1 year
Change in lipocalin-2
1 year
Changes in protein and inflammatory markers IGF-1
Time Frame: 1 year
Change in IGF-1
1 year
Changes in protein and inflammatory markers IL-6
Time Frame: 1 year
Change in IL-6
1 year
Changes in protein and inflammatory markers
Time Frame: 1 year
Change in testosterone
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Carel W le Roux, PhD, University College Dublin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 8, 2021

Primary Completion (ANTICIPATED)

October 3, 2022

Study Completion (ANTICIPATED)

October 3, 2022

Study Registration Dates

First Submitted

March 18, 2021

First Submitted That Met QC Criteria

March 19, 2021

First Posted (ACTUAL)

March 22, 2021

Study Record Updates

Last Update Posted (ACTUAL)

October 13, 2022

Last Update Submitted That Met QC Criteria

October 10, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RS20-012

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Weighted vest

3
Subscribe